Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase II Evaluation Of ABT-888, Topotecan And Filgrastim Or Pegfilgrastim In The Treatment Of Persistent Or Recurrent Squamous Or Non-Squamous Cell Carcinoma Of The Cervix.
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.